lunes, 2 de octubre de 2023

Effectiveness of molnupiravir vs nirmatrelvir-ritonavir in non-hospitalised and hospitalised patients with COVID-19: a target trial emulation study

https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(23)00402-9/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=covidalerts&utm_medium=email&_hsmi=276355044&_hsenc=p2ANqtz-_LdLioE5_qVE0_PlHpFl4iqgEqAA_4KaJonr7Tc4ckFzE6TWgaF30vqGDLQ6_S42n-StZrdC9pgyRWHInuus5mEkA89w&utm_content=276317812&utm_source=hs_email

No hay comentarios:

Publicar un comentario